D-0827-2020 Class III Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

FDA drug recall D-0827-2020 was initiated by Ascend Laboratories LLC on Jan 22, 2020 and is designated Class III. Reason for recall: Failed Dissolution Specifications: low out of specification results for dissolution testing. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 4728 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 12, 2020
Initiation Date
Jan 22, 2020
Termination Date
Oct 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4728 bottles

Product description

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Reason for recall

Failed Dissolution Specifications: low out of specification results for dissolution testing.

Distribution pattern

Nationwide in the USA

Code information

Lot #: 19140414, Exp 12/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0827-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0827-2020. Report a data issue: hello@regdatalab.com.